相关实验视频
Updated: Jun 16, 2026

10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
3.2K
[使用off-label设备关闭膜漏洞:一个有用的资源]
Emilio Herrera1, Alberto Navarro1, Julián Vanegas2
1Departamento de Medicina Interna, Universidad de Antioquia, Medellín, Colombia. Universidad de Antioquia Departamento de Medicina Interna Universidad de Antioquia Medellín Colombia.
Archivos peruanos de cardiologia y cirugia cardiovascular
|February 1, 2024
概括
这项研究详细介绍了机械主动脉假体中成功通过皮肤修复一个准膜泄漏的情况. 最少侵入性的方法使用了心室隔膜缺陷关闭装置,降低了患者的手术风险.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 假心漏 (PVLs) 是假心置换的潜在并发症.
- 机械大动脉假体可能会产生准膜泄漏,需要进行干预.
- 患者之前的手术增加了重新干预的术后风险.
研究的目的:
- 描述一种新的穿皮技术,用于对膜漏洞的关闭.
- 评估使用心室隔膜缺陷关闭装置用于修复大动脉准膜泄漏的可行性和安全性.
- 为了减少患有近期手术史的患者的术后风险.
主要方法:
- 通过皮肤关闭一个大动脉准膜泄漏.
- 在标签之外使用设计用于关闭心室隔膜缺陷的设备.
- 心声和临床随访以评估结果.
主要成果:
- 通过使用非标签设备,成功地完成了对膜漏洞的关闭.
- 这项手术没有出现手术内或即时并发症.
- 患者经历了一个没有并发症的随访期,这表明修复的有效性.
结论:
- 使用心室隔膜缺陷装置通过皮肤封闭准膜漏洞是一种可行的,不那么侵入性的选择.
- 这种技术可以有效地减少外科手术期间的风险,特别是在高风险患者中.
- 非标签使用的设备可以在复杂的心脏病例中提供成功的治疗替代方案.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

